Filtros : "Current Clinical Pharmacology" Limpar

Filtros



Refine with date range


  • Source: Current Clinical Pharmacology. Unidade: FCF

    Subjects: TUBERCULOSE, PRODUTOS NATURAIS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PRIMI, Marina Candido e SEGRETTI, Natanael Dante e FERREIRA, Elizabeth Igne. Medicinal chemistry of new compounds to treat tuberculosis. Current Clinical Pharmacology, v. 10, n. 2, p. 139-159, 2015Tradução . . Disponível em: https://doi.org/10.2174/1574884708666131229125103. Acesso em: 02 maio 2024.
    • APA

      Primi, M. C., Segretti, N. D., & Ferreira, E. I. (2015). Medicinal chemistry of new compounds to treat tuberculosis. Current Clinical Pharmacology, 10( 2), 139-159. doi:10.2174/1574884708666131229125103
    • NLM

      Primi MC, Segretti ND, Ferreira EI. Medicinal chemistry of new compounds to treat tuberculosis [Internet]. Current Clinical Pharmacology. 2015 ; 10( 2): 139-159.[citado 2024 maio 02 ] Available from: https://doi.org/10.2174/1574884708666131229125103
    • Vancouver

      Primi MC, Segretti ND, Ferreira EI. Medicinal chemistry of new compounds to treat tuberculosis [Internet]. Current Clinical Pharmacology. 2015 ; 10( 2): 139-159.[citado 2024 maio 02 ] Available from: https://doi.org/10.2174/1574884708666131229125103
  • Source: Current Clinical Pharmacology. Unidade: IQSC

    Subjects: TUBERCULOSE, VANÁDIO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Paula C et al. Vanadium complexes with hydrazone or Thiosemicarbazone ligands as potential anti-Mycobacterium turbeculosis agents. Current Clinical Pharmacology, v. 10, n. 1, p. 66-72, 2015Tradução . . Disponível em: https://doi.org/10.2174/157488470866131229124748. Acesso em: 02 maio 2024.
    • APA

      Souza, P. C., Maia, P. I. da S., Barros, H. B. de, Leite, C. Q. F., Deflon, V. M., & Pavan, F. R. (2015). Vanadium complexes with hydrazone or Thiosemicarbazone ligands as potential anti-Mycobacterium turbeculosis agents. Current Clinical Pharmacology, 10( 1), 66-72. doi:10.2174/157488470866131229124748
    • NLM

      Souza PC, Maia PI da S, Barros HB de, Leite CQF, Deflon VM, Pavan FR. Vanadium complexes with hydrazone or Thiosemicarbazone ligands as potential anti-Mycobacterium turbeculosis agents [Internet]. Current Clinical Pharmacology. 2015 ;10( 1): 66-72.[citado 2024 maio 02 ] Available from: https://doi.org/10.2174/157488470866131229124748
    • Vancouver

      Souza PC, Maia PI da S, Barros HB de, Leite CQF, Deflon VM, Pavan FR. Vanadium complexes with hydrazone or Thiosemicarbazone ligands as potential anti-Mycobacterium turbeculosis agents [Internet]. Current Clinical Pharmacology. 2015 ;10( 1): 66-72.[citado 2024 maio 02 ] Available from: https://doi.org/10.2174/157488470866131229124748

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024